Subsequent diagnostic tests indicated reduced dopamine transporter activity, which further supported the clinical suspicion of a complex neurodegenerative disorder associated with frontal dysfunction and parkinsonism. The gene discussed is SLC6A3; the disease is Parkinsonism.